Is Transcranial Direct Current Stimulation Effective for Cognitive Dysfunction in Substance Use Disorders? A Systematic Review

• Published in: Brain sciences 2024-07, Vol.14 (8), p.754
• Main Authors: Zhang, Xinbi, Huang, Mingming, Yu, Ying, Zhong, Xiaoke, Dai, Shengyu, Dai, Yuanfu, Jiang, Changhao
• Format: Article
• Language: English
• Subjects: Attentional bias; Bias; Brain mapping; Brain research; Clinical trials; Cocaine; Cognition disorders; Cognitive ability; cognitive dysfunction; cognitive function; Database searching; Drug therapy; Drug use; Electrical stimulation of the brain; ESB; Executive function; Functional magnetic resonance imaging; Internet/Web search services; Intervention; Magnetic resonance imaging; Memory; Narcotics; Neuroimaging; non-invasive brain stimulation; Online searching; Patient compliance; Patients; Psychotherapy; Quality of life; Side effects; Substance abuse; Substance use; Substance use disorder; substance use disorders; Systematic Review; tDCS; transcranial direct current stimulation
• ISSN: 2076-3425; 2076-3425
• DOI: 10.3390/brainsci14080754

Patients with substance use disorders (SUDs) often suffer from cognitive dysfunction (CD), affecting their quality of life and daily functioning. Current treatments, including pharmacotherapy and psychotherapy, have limited efficacy and notable side effects. Transcranial direct current stimulation (tDCS), a non-invasive technique that modulates cortical activity, shows promise in improving cognitive function with minimal side effects and low cost, and could potentially serve as a valuable adjunct to existing therapies. This systematic review aims to evaluate the literature on the effectiveness of tDCS for CD in SUD patients to inform clinical practice and future research. Following PRISMA guidelines, the review includes studies that used tDCS for SUD-related CD. The criteria for inclusion encompassed participants aged 18 and older with a diagnosis of SUD, the use of tDCS (either conventional or high-definition), control groups receiving sham stimulation or no intervention, and cognitive outcome measures for substance-related cognitive function using validated tools. Databases searched were Ovid MEDLINE, PubMed, Web of Science, Embase, Scopus, and PsycINFO, with specific keywords. Twenty-two studies met the criteria, suggesting tDCS can improve cognitive functions in SUD patients, though results varied. Effectiveness may depend on the brain area targeted, stimulation parameters, task requirements, and individual differences. tDCS shows potential in treating SUD-related CD, but further research is needed to optimize stimulation protocols and address study variability. Future studies should use functional magnetic resonance imaging to explore the brain mechanisms by which tDCS improves cognitive function in SUDs and focus on larger, long-term trials to confirm efficacy and refine tDCS treatment parameters.